AMASSE CAPITAL (08168) issued a total of 16 million shares due to the exercise of stock purchase rights.
Baoji Capital (08168) announced that on February 3, 2026, it exercised a total of 16 million shares issued under the share purchase plan adopted by the company on February 26, 2018.
AMASSE CAPITAL (08168) announced that on February 3, 2026, it has exercised a total of 16 million shares issued under the share option scheme adopted by the company on February 26, 2018.
Related Articles
XD INC (02400) spent HK$1.9458 million on February 3rd to repurchase 23,000 shares.
UNITED LAB (03933): UBT251 injection OSA indications granted clinical trial implied license.
Contemporary Amperex Technology (300750.SZ) has accumulated repurchased 15.99 million A-shares, with a total cost of 4.386 billion yuan.
XD INC (02400) spent HK$1.9458 million on February 3rd to repurchase 23,000 shares.
UNITED LAB (03933): UBT251 injection OSA indications granted clinical trial implied license.
Contemporary Amperex Technology (300750.SZ) has accumulated repurchased 15.99 million A-shares, with a total cost of 4.386 billion yuan.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
